Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Free Cash Flow (2021 - 2025)

Historic Free Cash Flow for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to -$112.7 million.

  • Core Scientific's Free Cash Flow fell 34268.49% to -$112.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$344.0 million, marking a year-over-year decrease of 117140.16%. This contributed to the annual value of -$52.1 million for FY2024, which is 20635.71% down from last year.
  • According to the latest figures from Q3 2025, Core Scientific's Free Cash Flow is -$112.7 million, which was down 34268.49% from -$87.3 million recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's Free Cash Flow peaked at $225.8 million during Q4 2021, and registered a low of -$165.1 million during Q2 2021.
  • Moreover, its 5-year median value for Free Cash Flow was -$15.0 million (2024), whereas its average is -$29.9 million.
  • As far as peak fluctuations go, Core Scientific's Free Cash Flow soared by 14149.51% in 2023, and later plummeted by 441988.61% in 2025.
  • Core Scientific's Free Cash Flow (Quarter) stood at $225.8 million in 2021, then crashed by 110.73% to -$24.2 million in 2022, then skyrocketed by 141.5% to $10.1 million in 2023, then plummeted by 248.67% to -$15.0 million in 2024, then plummeted by 653.78% to -$112.7 million in 2025.
  • Its Free Cash Flow stands at -$112.7 million for Q3 2025, versus -$87.3 million for Q2 2025 and -$129.0 million for Q1 2025.